MiNK Therapeutics, Inc. Business Finance Contracts & Agreements
7 Contracts & Agreements
- Note Agreements (3 contracts)
- Stock Agreements (3)
- Underwriting Agreements (1)
- MiNK Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on October 12, 2021)
- Amendment to Convertible Promissory Note, by and between MINK Therapeutics, Inc. and Agenus Inc., dated September 29, 2021 (Filed With SEC on October 12, 2021)
- Specimen stock certificate evidencing shares of common stock (Filed With SEC on October 12, 2021)
- Form of Underwriting Agreement (Filed With SEC on October 12, 2021)
- Restricted Stock Award Agreement between AgenTus Therapeutics, Inc. and Patrick Jordan, dated November 5, 2020 (Filed With SEC on September 14, 2021)
- Convertible Promissory Note Purchase Agreement, by and between AgenTus Therapeutics, Inc. and Agenus Inc., dated February 11, 2021 (Filed With SEC on September 14, 2021)
- Convertible Promissory Note, by and between AgenTus Therapeutics, Inc. and Agenus Inc., dated February 11, 2021 (Filed With SEC on September 14, 2021)